KAM
NXTM

Kassirer Asset Management’s NxStage Medical Inc. NXTM Stock Holding History

Kassirer Asset Management’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-20,000
Closed -$558K – 57
2018
Q3 		$558K Hold
20,000
– – 0.37% 47
2018
Q2 		$558K Sell
20,000
-20,000
-50% -$536K 0.36% 51
2018
Q1 		$994K Hold
40,000
– – 0.58% 44
2017
Q4 		$969K Buy
40,000
+20,000
+100% +$527K 1% 30
2017
Q3 		$552K Buy
+20,000
New +$533K 0.52% 42

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kassirer Asset Management's NXTM Position: Q4 2018 in Review

Kassirer Asset Management sold out of NxStage Medical Inc. (NXTM) in Q4 2018, closing a stake of 20,000 shares — an estimated $558K sold.

Kassirer Asset Management first reported a position in NXTM in Q3 2017 and held it in 5 quarters. The position peaked at $994K in Q1 2018. 172 funds tracked by Wall St. Rank hold NXTM as of Q4 2018.

  • Kassirer Asset Management reported no remaining NxStage Medical Inc. position as of Q4 2018 after selling out during the quarter.
  • Kassirer Asset Management sold 20,000 NxStage Medical Inc. shares in Q4 2018, an estimated $558K.
  • Kassirer Asset Management first reported a position in NxStage Medical Inc. in Q3 2017 and held it in 5 quarters.
  • Kassirer Asset Management's NxStage Medical Inc. position peaked at $994K in Q1 2018.
  • 172 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2018.

Based on Kassirer Asset Management's 13F filing for Q4 2018, filed 30 Jan 2019.